Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.7
Powered by Cell Signaling Technology
Home > Curated Information Page > Cst Curation Set #5637
Rikova K (2008) CST Curation Set: 5637; Year: 2008; Biosample/Treatment: cell line, H2228 silac4/inhibitor; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: RXXp[ST] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Akt Substrate (RXRXXS*/T*) (23C8D2) Rabbit mAb Cat#: 10001, PTMScan(R) Phospho-Akt Substrate Motif (RXRXXS*/T*) Immunoaffinity Beads Cat#: 1979
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

T238-p - Abi-1 (human)
Modsite: sLNQRPRtHsGssGG SwissProt Entrez-Gene
Orthologous residues
Abi‑1 (human): T238‑p, Abi‑1 iso2 (human): T233‑p, Abi‑1 iso3 (human): T238‑p, Abi‑1 iso11 (human): T174‑p, Abi‑1 iso12 (human): T255‑p, Abi‑1 (mouse): T238‑p, Abi‑1 iso4 (mouse): T233‑p, Abi‑1 (rat): T233‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S242-p - Abi-1 (human)
Modsite: RPRtHsGssGGsGsR SwissProt Entrez-Gene
Orthologous residues
Abi‑1 (human): S242‑p, Abi‑1 iso2 (human): S237‑p, Abi‑1 iso3 (human): S242‑p, Abi‑1 iso11 (human): S178‑p, Abi‑1 iso12 (human): S259‑p, Abi‑1 (mouse): S242‑p, Abi‑1 iso4 (mouse): S237‑p, Abi‑1 (rat): S237‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

T238-p - Abi-1 iso3 (human)
Modsite: SLNQRPRtHsGsSGG SwissProt Entrez-Gene
Orthologous residues
Abi‑1 (human): T238‑p, Abi‑1 iso2 (human): T233‑p, Abi‑1 iso3 (human): T238‑p, Abi‑1 iso11 (human): T174‑p, Abi‑1 iso12 (human): T255‑p, Abi‑1 (mouse): T238‑p, Abi‑1 iso4 (mouse): T233‑p, Abi‑1 (rat): T233‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S242-p - Abi-1 iso3 (human)
Modsite: RPRtHsGsSGGSGsR SwissProt Entrez-Gene
Orthologous residues
Abi‑1 (human): S242‑p, Abi‑1 iso2 (human): S237‑p, Abi‑1 iso3 (human): S242‑p, Abi‑1 iso11 (human): S178‑p, Abi‑1 iso12 (human): S259‑p, Abi‑1 (mouse): S242‑p, Abi‑1 iso4 (mouse): S237‑p, Abi‑1 (rat): S237‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S1126-p - Afadin (human)
Modsite: sGKPRPKsEGFELyN SwissProt Entrez-Gene
Orthologous residues
Afadin (human): S1126‑p, Afadin iso2 (human): S1110‑p, Afadin iso3 (human): S1109‑p, Afadin iso5 (human): S1125‑p, Afadin (mouse): S1126‑p, Afadin iso2 (mouse): S1111‑p, Afadin (rat): S1133‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S1109-p - Afadin iso3 (human)
Modsite: SGKPRPKsEGFELYN SwissProt Entrez-Gene
Orthologous residues
Afadin (human): S1126‑p, Afadin iso2 (human): S1110‑p, Afadin iso3 (human): S1109‑p, Afadin iso5 (human): S1125‑p, Afadin (mouse): S1126‑p, Afadin iso2 (mouse): S1111‑p, Afadin (rat): S1133‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S1151-p - DISP2 (human)
Modsite: AGRPRPGsVGGMPGS SwissProt Entrez-Gene
Orthologous residues
DISP2 (human): S1151‑p, DISP2 (mouse): , DISP2 (rat):
Characterization
Methods used to characterize site in vivo mass spectrometry

S409-p - EIF4B (human)
Modsite: ERHPsWRsEEtQERE SwissProt Entrez-Gene
Orthologous residues
EIF4B (human): S409‑p, EIF4B (mouse): S409‑p, EIF4B (rat): S409‑p, EIF4B (cow): S409‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S418-p - EIF4B (human)
Modsite: EtQERERsRtGsEss SwissProt Entrez-Gene
Orthologous residues
EIF4B (human): S418‑p, EIF4B (mouse): S418‑p, EIF4B (rat): S418‑p, EIF4B (cow): S418‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S422-p - EIF4B (human)
Modsite: RERsRtGsEssQtGt SwissProt Entrez-Gene
Orthologous residues
EIF4B (human): S422‑p, EIF4B (mouse): S422‑p, EIF4B (rat): S422‑p, EIF4B (cow): S422‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S284-p - FAM21A (human)
Modsite: ENTRPKRsRPtsFAD SwissProt Entrez-Gene
Orthologous residues
FAM21A (human): S284‑p, FAM21A iso2 (human): S284‑p, FAM21A iso3 (human): S284‑p, FAM21A (mouse): , FAM21A (rat):
Characterization
Methods used to characterize site in vivo mass spectrometry

T287-p - FAM21A (human)
Modsite: RPKRsRPtsFADELA SwissProt Entrez-Gene
Orthologous residues
FAM21A (human): T287‑p, FAM21A iso2 (human): T287‑p, FAM21A iso3 (human): T287‑p, FAM21A (mouse): T283‑p, FAM21A (rat): T282‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S288-p - FAM21A (human)
Modsite: PKRsRPtsFADELAA SwissProt Entrez-Gene
Orthologous residues
FAM21A (human): S288‑p, FAM21A iso2 (human): S288‑p, FAM21A iso3 (human): S288‑p, FAM21A (mouse): S284‑p, FAM21A (rat): S283‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S1957-p - FRYL (human)
Modsite: RRGDRRRsNtLDIMD SwissProt Entrez-Gene
Orthologous residues
FRYL (human): S1957‑p, FRYL (mouse): S1958‑p, FRYL (rat): S1957‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S26-p - GMPR2 (human)
Modsite: PkRSTLKsRsEVDLT SwissProt Entrez-Gene
Orthologous residues
GMPR2 (human): S26‑p, GMPR2 iso2 (human): S44‑p, GMPR2 iso3 (human): S26‑p, GMPR2 (mouse): S26‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S28-p - GMPR2 (human)
Modsite: RSTLKsRsEVDLTRS SwissProt Entrez-Gene
Orthologous residues
GMPR2 (human): S28‑p, GMPR2 iso2 (human): S46‑p, GMPR2 iso3 (human): S28‑p, GMPR2 (mouse): S28‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S37-p - GMPR2 (human)
Modsite: VDLTRSFsFRNSKQT SwissProt Entrez-Gene
Orthologous residues
GMPR2 (human): S37‑p, GMPR2 iso2 (human): S55‑p, GMPR2 iso3 (human): S37‑p, GMPR2 (mouse): S37‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S826-p - GRID2IP (human)
Modsite: GHRRSETsHMsVKRL SwissProt Entrez-Gene
Orthologous residues
GRID2IP (human): S826‑p, GRID2IP (mouse): S818‑p, GRID2IP iso2 (mouse): S639‑p, GRID2IP (rat): S637‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

T257-p - LARP7 (human)
Modsite: KMKRsRPtsEGsDIE SwissProt Entrez-Gene
Orthologous residues
LARP7 (human): T257‑p, LARP7 iso2 (human): , LARP7 (mouse): T251‑p, LARP7 (rat): T252‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S258-p - LARP7 (human)
Modsite: MKRsRPtsEGsDIEs SwissProt Entrez-Gene
Orthologous residues
LARP7 (human): S258‑p, LARP7 iso2 (human): , LARP7 (mouse): S253‑p, LARP7 (rat): S254‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S261-p - LARP7 (human)
Modsite: sRPtsEGsDIEstEP SwissProt Entrez-Gene
Orthologous residues
LARP7 (human): S261‑p, LARP7 iso2 (human): , LARP7 (mouse): S256‑p, LARP7 (rat): S257‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

T17-p - LATS1 (human)
Modsite: YRQMRPKtFPASNyT SwissProt Entrez-Gene
Orthologous residues
LATS1 (human): T17‑p, LATS1 (mouse): T17‑p, LATS1 (rat): T17‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

T19-p - MRLC1 (human)
Modsite: KKRPQRAtsNVFAMF SwissProt Entrez-Gene
Orthologous residues
MRLC1 (human): T19‑p, MRLC1 (mouse): T19‑p, MRLC1 (rat): T19‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S20-p - MRLC1 (human)
Modsite: KRPQRAtsNVFAMFD SwissProt Entrez-Gene
Orthologous residues
MRLC1 (human): S20‑p, MRLC1 (mouse): S20‑p, MRLC1 (rat): S20‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

T19-p - MRLC2 (human)
Modsite: KKRPQRAtsNVFAMF SwissProt Entrez-Gene
Orthologous residues
MRLC2 (human): T19‑p, MRLC2 (mouse): T19‑p, MRLC2 (rat): T19‑p, MRLC2 (cow): T19‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S20-p - MRLC2 (human)
Modsite: KRPQRAtsNVFAMFD SwissProt Entrez-Gene
Orthologous residues
MRLC2 (human): S20‑p, MRLC2 (mouse): S20‑p, MRLC2 (rat): S20‑p, MRLC2 (cow): S20‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

T15-p - MRPL27 (human)
Modsite: LRTRTAVtsLLSPTP SwissProt Entrez-Gene
Orthologous residues
MRPL27 (human): T15‑p, MRPL27 (mouse): T15‑p, MRPL27 (rat): , MRPL27 (cow): I15‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S16-p - MRPL27 (human)
Modsite: RTRTAVtsLLSPTPA SwissProt Entrez-Gene
Orthologous residues
MRPL27 (human): S16‑p, MRPL27 (mouse): A16‑p, MRPL27 (rat): A16‑p, MRPL27 (cow): A16‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S32-p - MRPL27 (human)
Modsite: ALAVRYAsKKSGGSS SwissProt Entrez-Gene
Orthologous residues
MRPL27 (human): S32‑p, MRPL27 (mouse): S32‑p, MRPL27 (rat): S32‑p, MRPL27 (cow): S32‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

T356-p - NDRG1 (human)
Modsite: GtRsRsHtsEGtRsR SwissProt Entrez-Gene
Orthologous residues
NDRG1 (human): T356‑p, NDRG1 iso2 (human): T290‑p, NDRG1 iso3 (human): T275‑p, NDRG1 (mouse): T356‑p, NDRG1 (rat): T356‑p, NDRG1 (cow):
Characterization
Methods used to characterize site in vivo mass spectrometry

S357-p - NDRG1 (human)
Modsite: tRsRsHtsEGtRsRs SwissProt Entrez-Gene
Orthologous residues
NDRG1 (human): S357‑p, NDRG1 iso2 (human): S291‑p, NDRG1 iso3 (human): S276‑p, NDRG1 (mouse): S357‑p, NDRG1 (rat): S357‑p, NDRG1 (cow):
Characterization
Methods used to characterize site in vivo mass spectrometry

S362-p - NDRG1 (human)
Modsite: HtsEGtRsRsHtsEG SwissProt Entrez-Gene
Orthologous residues
NDRG1 (human): S362‑p, NDRG1 iso2 (human): S296‑p, NDRG1 iso3 (human): S281‑p, NDRG1 (mouse): S362‑p, NDRG1 (rat): S362‑p, NDRG1 (cow): S352‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S364-p - NDRG1 (human)
Modsite: sEGtRsRsHtsEGAH SwissProt Entrez-Gene
Orthologous residues
NDRG1 (human): S364‑p, NDRG1 iso2 (human): S298‑p, NDRG1 iso3 (human): S283‑p, NDRG1 (mouse): S364‑p, NDRG1 (rat): S364‑p, NDRG1 (cow): S354‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

T366-p - NDRG1 (human)
Modsite: GtRsRsHtsEGAHLD SwissProt Entrez-Gene
Orthologous residues
NDRG1 (human): T366‑p, NDRG1 iso2 (human): T300‑p, NDRG1 iso3 (human): T285‑p, NDRG1 (mouse): T366‑p, NDRG1 (rat): T366‑p, NDRG1 (cow): T356‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

T112-p - Pumilio-1 (human)
Modsite: NskHRWPtGDNIHAE SwissProt Entrez-Gene
Orthologous residues
Pumilio‑1 (human): T112‑p, Pumilio‑1 iso2 (human): T112‑p, Pumilio‑1 iso4 (human): T148‑p, Pumilio‑1 (mouse): T112‑p, Pumilio‑1 (rat): T112‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S1394-p - Ron (human)
Modsite: VRRPRPLsEPPRPT_ SwissProt Entrez-Gene
Orthologous residues
Ron (human): S1394‑p, Ron iso2 (human): S1345‑p, Ron (mouse): S1372‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S532-p - SARG (human)
Modsite: NSRPRPAsLGTGKDF SwissProt Entrez-Gene
Orthologous residues
SARG (human): S532‑p, SARG iso2 (human): S286‑p, SARG (mouse): S537‑p, SARG (rat): S535‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

T916-p - SETD1A (human)
Modsite: EkRPRPstPAEEDED SwissProt Entrez-Gene
Orthologous residues
SETD1A (human): T916‑p, SETD1A (mouse): T931‑p, SETD1A (rat): T929‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

T289-p - SRm300 (human)
Modsite: AAAktHttALAGRsP SwissProt Entrez-Gene
Orthologous residues
SRm300 (human): T289‑p, SRm300 iso2 (human): T289‑p, SRm300 (mouse): T289‑p, SRm300 iso2 (mouse): T193‑p, SRm300 iso3 (mouse): T289‑p, SRm300 (rat): T289‑p, SRm300 (cow): T289‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S295-p - SRm300 (human)
Modsite: ttALAGRsPsPAsGR SwissProt Entrez-Gene
Orthologous residues
SRm300 (human): S295‑p, SRm300 iso2 (human): S295‑p, SRm300 (mouse): S295‑p, SRm300 iso2 (mouse): S199‑p, SRm300 iso3 (mouse): S295‑p, SRm300 (rat): S295‑p, SRm300 (cow): S295‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S297-p - SRm300 (human)
Modsite: ALAGRsPsPAsGRRG SwissProt Entrez-Gene
Orthologous residues
SRm300 (human): S297‑p, SRm300 iso2 (human): S297‑p, SRm300 (mouse): P297‑p, SRm300 iso2 (mouse): P201‑p, SRm300 iso3 (mouse): P297‑p, SRm300 (rat): P297‑p, SRm300 (cow): S297‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S284-p - WASHC2C (human)
Modsite: ENTRPKRsRPtsFAD SwissProt Entrez-Gene
Orthologous residues
WASHC2C (human): S284‑p, WASHC2C iso2 (human): S276‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

T287-p - WASHC2C (human)
Modsite: RPKRsRPtsFADELA SwissProt Entrez-Gene
Orthologous residues
WASHC2C (human): T287‑p, WASHC2C iso2 (human): T279‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S288-p - WASHC2C (human)
Modsite: PKRsRPtsFADELAA SwissProt Entrez-Gene
Orthologous residues
WASHC2C (human): S288‑p, WASHC2C iso2 (human): S280‑p
Characterization
Methods used to characterize site in vivo mass spectrometry

S1183-p - YTHDC2 (human)
Modsite: GQRPRPMssEELPLA SwissProt Entrez-Gene
Orthologous residues
YTHDC2 (human): S1183‑p, YTHDC2 (mouse): S1198‑p, YTHDC2 (rat): S1184‑p
Characterization
Methods used to characterize site in vivo mass spectrometry